Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party.
Sculier JP, Klastersky J, Libert P, Ravez P, Thiriaux J, Lecomte J, Bureau G, Vandermoten G, Dabouis G, Michel J, et al. Sculier JP, et al. Among authors: michel j. Ann Oncol. 1990;1(2):128-33. doi: 10.1093/oxfordjournals.annonc.a057690. Ann Oncol. 1990. PMID: 1964073 Free article. Clinical Trial.
Adjuvant immunotherapy by levamisole in resectable lung cancer: a control study.
Van Houtte P, Bondue H, Rocmans P, Michel J, Wybran J, Dalesio O, Balikdjian D, Vanderhoeft P, Kenis Y. Van Houtte P, et al. Among authors: michel j. Eur J Cancer (1965). 1980 Dec;16(12):1597-601. doi: 10.1016/0014-2964(80)90033-x. Eur J Cancer (1965). 1980. PMID: 7014227 Clinical Trial. No abstract available.
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
Sculier JP, Paesmans M, Bureau G, Dabouis G, Libert P, Vandermoten G, Van Cutsem O, Berchier MC, Ries F, Michel J, et al. Sculier JP, et al. Among authors: michel j. J Clin Oncol. 1993 Oct;11(10):1858-65. doi: 10.1200/JCO.1993.11.10.1858. J Clin Oncol. 1993. PMID: 8410110 Clinical Trial.
Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC Lung Cancer Working Party (Belgium).
Klastersky J, Sculier JP, Dumont JP, Becquart D, Vandermoten G, Rocmans P, Michel J, Longeval E, Dalesio O. Klastersky J, et al. Among authors: michel j. Cancer. 1985 Jul 1;56(1):71-5. doi: 10.1002/1097-0142(19850701)56:1<71::aid-cncr2820560112>3.0.co;2-9. Cancer. 1985. PMID: 2988738 Clinical Trial.
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Bureau G, Giner V, Lecomte J, Michel J, Berchier MC, Van Cutsem O, Küstner U, Kroll F, Sergysels R, Mommen P, Klastersky J. Sculier JP, et al. Among authors: michel j. J Clin Oncol. 1996 Aug;14(8):2337-44. doi: 10.1200/JCO.1996.14.8.2337. J Clin Oncol. 1996. PMID: 8708726 Clinical Trial.
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.
Piccart MJ, Di Leo A, Beauduin M, Vindevoghel A, Michel J, Focan C, Tagnon A, Ries F, Gobert P, Finet C, Closon-Dejardin MT, Dufrane JP, Kerger J, Liebens F, Beauvois S, Bartholomeus S, Dolci S, Lobelle JP, Paesmans M, Nogaret JM. Piccart MJ, et al. Among authors: michel j. J Clin Oncol. 2001 Jun 15;19(12):3103-10. doi: 10.1200/JCO.2001.19.12.3103. J Clin Oncol. 2001. PMID: 11408507 Clinical Trial.
Phase II trial with chlorozotocin in advanced colorectal cancer.
Bleiberg H, Rozencweig M, Michel J, Clavel M, Longeval E, Feremans W, Bondue H, Lardinois J, Crespeigne N, Kenis Y. Bleiberg H, et al. Among authors: michel j. Eur J Cancer Clin Oncol. 1981 Aug;17(8):863-6. doi: 10.1016/0014-2964(81)90306-6. Eur J Cancer Clin Oncol. 1981. PMID: 6459936 No abstract available.
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions.
Ferreira Filho AF, Di Leo A, Paesmans M, Beauduin M, Vindevoghel A, Michel J, Focan C, Awada A, Cardoso F, Dolci S, Bartholomeus S, Piccart MJ. Ferreira Filho AF, et al. Among authors: michel j. Ann Oncol. 2002 Mar;13(3):416-21. doi: 10.1093/annonc/mdf051. Ann Oncol. 2002. PMID: 11996473 Free article. Clinical Trial.
2,625 results